FDA review staff was excluded from voting on whether to approve first priority voucher drug In major break from precedent, Prasad, Tidmarsh, Høeg, and other top leaders led the decision

https://www.statnews.com/2025/11/21/top-leaders-not-fda-reviewers-voted-on-first-priority-voucher-drug/